BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30466750)

  • 21. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
    Quesada AE; Routbort MJ; DiNardo CD; Bueso-Ramos CE; Kanagal-Shamanna R; Khoury JD; Thakral B; Zuo Z; Yin CC; Loghavi S; Ok CY; Wang SA; Tang Z; Bannon SA; Benton CB; Garcia-Manero G; Kantarjian H; Luthra R; Medeiros LJ; Patel KP
    Am J Hematol; 2019 Jul; 94(7):757-766. PubMed ID: 30963592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
    Hamadou WS; Mani R; Besbes S; Bourdon V; Youssef YB; Eisinger F; Mari V; Gesta P; Dreyfus H; Bonadona V; Dugast C; Zattara H; Faivre L; Noguchi T; Khélif A; Sobol H; Soua Z
    Ann Hematol; 2017 Oct; 96(10):1635-1639. PubMed ID: 28752392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid neoplasms with germline DDX41 mutation.
    Cheah JJC; Hahn CN; Hiwase DK; Scott HS; Brown AL
    Int J Hematol; 2017 Aug; 106(2):163-174. PubMed ID: 28547672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.
    Yannakou CK; Jones K; Ryland GL; Thompson ER; Reid G; McBean M; Trainer A; Westerman D; Blombery P
    J Clin Pathol; 2018 Jan; 71(1):84-87. PubMed ID: 28801348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial myelodysplasia and acute myeloid leukaemia--a review.
    Owen C; Barnett M; Fitzgibbon J
    Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
    Gao J; Gong S; Chen YH
    Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical and genomic landscape of patients with DDX41 variants identified during diagnostic sequencing.
    Maierhofer A; Mehta N; Chisholm RA; Hutter S; Baer C; Nadarajah N; Pohlkamp C; Thompson ER; James PA; Kern W; Haferlach C; Meggendorfer M; Haferlach T; Blombery P
    Blood Adv; 2023 Dec; 7(23):7346-7357. PubMed ID: 37874914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
    J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
    Babushok DV; Bessler M; Olson TS
    Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia].
    Király PA; Kállay K; Marosvári D; Benyó G; Szőke A; Csomor J; Bödör C
    Orv Hetil; 2016 Feb; 157(8):283-9. PubMed ID: 26876264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.
    Yang F; Long N; Anekpuritanang T; Bottomly D; Savage JC; Lee T; Solis-Ruiz J; Borate U; Wilmot B; Tognon C; Bock AM; Pollyea DA; Radhakrishnan S; Radhakrishnan S; Patel P; Collins RH; Tantravahi S; Deininger MW; Fan G; Druker B; Shinde U; Tyner JW; Press RD; McWeeney S; Agarwal A
    Blood; 2022 Feb; 139(8):1208-1221. PubMed ID: 34482403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
    Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
    Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline ETV6 mutations and predisposition to hematological malignancies.
    Feurstein S; Godley LA
    Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline Genetic Predisposition to Hematologic Malignancy.
    Furutani E; Shimamura A
    J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications.
    Godley LA; DiNardo CD; Bolton K
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432218. PubMed ID: 38768412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of familial myeloid neoplasia in adults.
    Brown AL; Churpek JE; Malcovati L; Döhner H; Godley LA
    Semin Hematol; 2017 Apr; 54(2):60-68. PubMed ID: 28637618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germ line predisposition to myeloid malignancies appearing in adulthood.
    Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
    Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
    Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
    Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan.
    Yoshimi A; Toya T; Nannya Y; Takaoka K; Kirito K; Ito E; Nakajima H; Hayashi Y; Takahashi T; Moriya-Saito A; Suzuki K; Harada H; Komatsu N; Usuki K; Ichikawa M; Kurokawa M
    Ann Oncol; 2016 May; 27(5):887-95. PubMed ID: 26884589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
    Lewinsohn M; Brown AL; Weinel LM; Phung C; Rafidi G; Lee MK; Schreiber AW; Feng J; Babic M; Chong CE; Lee Y; Yong A; Suthers GK; Poplawski N; Altree M; Phillips K; Jaensch L; Fine M; D'Andrea RJ; Lewis ID; Medeiros BC; Pollyea DA; King MC; Walsh T; Keel S; Shimamura A; Godley LA; Hahn CN; Churpek JE; Scott HS
    Blood; 2016 Feb; 127(8):1017-23. PubMed ID: 26712909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.